The global metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.8% during the forecast period. The rising prevalence of chronic diseases and rising awareness regarding metabolic disorders is contributing to the growth of the market. As per the World Health Organization (WHO), global obesity has approximately tripled since 1975. In 2016, over 1.9 million adults, aged 18 years and more were overweight and among these, 650 million were obese. In 2016, 39% of adults aged 18 years and more were overweight and 13% were obese. A metabolic disorder is closely associated with obesity, overweight, and inactivity. It is also associated with the condition referred to as insulin resistance.
Get Free Sample link @ https://www.omrglobal.com/request-sample/metabolic-disorder-therapeutics-market
Obesity and overweight are significant risk factors for the development of metabolic syndrome. As per Diabetes UK, obesity is expected to account for 80-85% of the risk of developing type 2 diabetes. Metabolic syndrome is one of the major public health threats and is associated with increased risk of type-2 diabetes, non-alcoholic fatty liver disease (NAFLD), and heart disease, which can lead to liver cancer and liver fibrosis. Therefore, increasing obese population leads to an increased risk of developing metabolic syndrome in the obese population. This, in turn, drives the demand for therapies used for metabolic disorders such as enzyme replacement therapy, drug therapy, and gene therapy.
A full report of Global Metabolic Disorder Therapeutics Market available @ https://www.omrglobal.com/industry-reports/metabolic-disorder-therapeutics-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Metabolic Disorder Therapeutics Market by Therapy
- Drug Therapy
- Gene Therapy
- Cellular Transplantation
- Enzyme Replacement Therapy
- Others
Global Metabolic Disorder Therapeutics Market by Disease
- Obesity
- Diabetes
- Lysosomal Storage Disease
- Hypercholesterolemia
- Others
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- AbbVie, Inc.
- Actelion Pharmaceuticals, Ltd.
- Agios Pharmaceuticals, Inc.
- Alexion Pharmaceuticals, Inc.
- Amgen, Inc.
- AstraZeneca plc
- Biocon, Ltd.
- BioMarin Pharmaceutical, Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Co.
- Cipla, Inc.
- CymaBay Therapeutics, Inc.
- Dracen Pharmaceuticals, Inc.
- Eli Lilly and Co.
- Intra-Cellular Therapies, Inc.
- Merck KGaA
- Novo Nordisk A/S
- Orchard Therapeutics plc
- Pfizer, Inc.
- Sanofi S.A.
- Shire Pharmaceuticals Group plc
- Sigilon Therapeutics, Inc.
- Silence Therapeutics
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global metabolic disorder therapeutics market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/metabolic-disorder-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
